Microwave zapper could replace lung surgery for some cancers

NCT ID NCT06869122

Recruiting now Disease control Sponsor: Creo Medical Limited Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device that uses microwave energy to heat and destroy lung tumors. 18 people with lung cancer who are already scheduled for surgery will receive this ablation first. The goal is to see if the device is safe and can effectively kill the tumor, which might one day allow patients to avoid surgery altogether.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Microwave ablation device (MicroBlate Flex)
What this could lead to: If successful, this technique could offer a less invasive option for treating lung tumors, potentially avoiding the need for surgery in future patients.
What could go wrong: This is a very early, small study (18 people) focused on safety and technical success, not on long-term outcomes. The ablation is done before planned surgery, so it's not yet a standalone treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

Istituto Europeo di Oncologia (IEO), Via Ripamonti 435
NOT_YET_RECRUITING

Milan, 20141, Italy
Royal Brompton and Harefield NHS Foundation Trust, Royal Brompton Hospital, Sydney Street
RECRUITING

London, UK, SW3 6NP, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.